284 related articles for article (PubMed ID: 25133669)
1. Coinfection with human herpesvirus 8 is associated with persistent inflammation and immune activation in virologically suppressed HIV-infected patients.
Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; Lumbreras B; Hernández I; Gutiérrez F
PLoS One; 2014; 9(8):e105442. PubMed ID: 25133669
[TBL] [Abstract][Full Text] [Related]
2. Increased carotid intima-media thickness associated with antibody responses to varicella-zoster virus and cytomegalovirus in HIV-infected patients.
Masiá M; Robledano C; Ortiz de la Tabla V; Antequera P; López N; Gutiérrez F
PLoS One; 2013; 8(5):e64327. PubMed ID: 23717597
[TBL] [Abstract][Full Text] [Related]
3. Contribution of Human Herpesvirus 8 and Herpes Simplex Type 2 to Progression of Carotid Intima-Media Thickness in People Living With HIV.
Lidón F; Padilla S; García JA; Fernández M; García J; Ortiz de la Tabla V; Gutiérrez F; Masiá M
Open Forum Infect Dis; 2019 Feb; 6(2):ofz041. PubMed ID: 30815506
[TBL] [Abstract][Full Text] [Related]
4. T-cell phenotypes, apoptosis and inflammation in HIV+ patients on virologically effective cART with early atherosclerosis.
Merlini E; Luzi K; Suardi E; Barassi A; Cerrone M; Martínez JS; Bai F; D'Eril GV; Monforte AD; Marchetti G
PLoS One; 2012; 7(9):e46073. PubMed ID: 23029393
[TBL] [Abstract][Full Text] [Related]
5. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
[TBL] [Abstract][Full Text] [Related]
6. Serum apoptosis markers in HIV-infected patients with human herpesvirus type 8 and herpes simplex virus type 2 co-infection.
Dakovic Rode O; Markotic A; Kujundzic Tiljak M; Zidovec Lepej S; Begovac J
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3303-8. PubMed ID: 22837067
[TBL] [Abstract][Full Text] [Related]
7. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
8. Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.
Foster WR; Bischin A; Dorer R; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):311-21. PubMed ID: 27234438
[TBL] [Abstract][Full Text] [Related]
9. HIV/Human herpesvirus co-infections: Impact on tryptophan-kynurenine pathway and immune reconstitution.
Yap SH; Abdullah NK; McStea M; Takayama K; Chong ML; Crisci E; Larsson M; Azwa I; Kamarulzaman A; Leong KH; Woo YL; Rajasuriar R
PLoS One; 2017; 12(10):e0186000. PubMed ID: 29016635
[TBL] [Abstract][Full Text] [Related]
10. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
11. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
[TBL] [Abstract][Full Text] [Related]
12. Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.
Kovacs A; Karim R; Mack WJ; Xu J; Chen Z; Operskalski E; Frederick T; Landay A; Voris J; Spencer LS; Young MA; Tien PC; Augenbraun M; Strickler HD; Al-Harthi L
J Infect Dis; 2010 Mar; 201(6):823-34. PubMed ID: 20151840
[TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
16. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ cytokines in HIV/HHV-8 coinfection.
Silva DMD; Gonçales JP; Silva Júnior JVJ; Lopes TRR; Bezerra LA; Barros de Lorena VM; Duarte Coêlho MRC
J Med Virol; 2021 Jun; 93(6):4033-4037. PubMed ID: 32926412
[TBL] [Abstract][Full Text] [Related]
18. High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population.
Feiterna-Sperling C; Königs C; Notheis G; Buchholz B; Krüger R; Weizsäcker K; Eberle J; Hanhoff N; Gärtner B; Heider H; Krüger DH; Hofmann J
Med Microbiol Immunol; 2016 Oct; 205(5):425-34. PubMed ID: 27240652
[TBL] [Abstract][Full Text] [Related]
19. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
[TBL] [Abstract][Full Text] [Related]
20. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
